Agilent's liquid chromatography and mass spec systems listed as Class I medical devices with FDA

Agilent Technologies Inc. today announced that it has listed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical devices with the U.S. Food and Drug Administration.

“The latest generation of liquid chromatography and mass spec systems that Agilent has registered holds tremendous value for the medical community”

"The latest generation of liquid chromatography and mass spec systems that Agilent has registered holds tremendous value for the medical community," said Gustavo Salem, Agilent vice president and general manager, Biological Systems Division. "We're being very methodical in bringing this technology to the clinic, while ensuring that the equipment meets the laboratories' needs."

The Infinity Series1200 is manufactured in Waldbronn, Germany, and the 6000 Series is manufactured in Singapore. Both facilities are registered as medical device establishments with the FDA, a requirement for manufacturing medical devices. In September 2011, those facilities were certified as meeting the internationally recognized ISO 13485 quality-management standard. In June 2011, Agilent's reagent manufacturing facility in Cedar Creek, Texas, was registered with the FDA as a medical device establishment.

Source:

 Agilent Technologies

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Do phthalates in face masks pose health hazards with increased usage during the COVID-19 pandemic?